~~<i id='210694C49A'><strike id='210694C49A'><tt id='210694C49A'><pre id='210694C49A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

explore

author：knowledge 2025-10-02 00:40:24 - browse：9534

J.P. Morgan office building at night -- JPM health business coverage from STAT — Adobe

SAN FRANCISCO — Almost three years ago, the country’s biggest bank unveiled a lofty plan to fix the health care industry’s entrenched problems. It broke off $250 million to stand up a new business unit, Morgan Health, to do so.

Today, Morgan Health’s CEO, Dan Mendelson, aided by a newly hired flack, emailed reporters attending that bank’s annual investor confab, the J.P. Morgan Healthcare Conference, asking them for interviews. For the uninitiated, it’s usually the other way around.

Their message? We’re still here.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Senators push IRS to launch nonprofit hospital probe

entertainment

focus

leisure time

explore

focus

hotspot

9:50EducationSecretaryMiguelCardonaspeaksduringaback-to-schoolK-12CybersecuritySummitintheEastRoomof

WSS

Health AI: on the border between health care and tech

A disappointing year of Humira biosimilars

Senators start work on Medicare physician payment reform

'Revelatory' study finds a smoking impact that remains after quitting

Hospitals are dialing back on venture capital investing

Bird flu researchers hone in on Finland’s mink farms

knowledge

explore

entertainment

Continuity nursing helped my family in our darkest PICU moments

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Duchenne breakthrough therapy leaves behind pioneering families

To avoid data mishandling cases, universities eye AI and other tools

At least 13 dead in Texas as scorching temps continue

Gilead might be held responsible for not developing a drug

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Trump demands the U.S. pay no more for drugs than other countries … again

Biden report: The neurospychology of memory and aging

focus

Hospitals are dialing back on venture capital investing

Illumina slashes 2023 revenue projections yet again

Treatments for cramps don't cut it. Why aren't there better options?

PhRMA lawsuit over Medicare drug price negotiation tossed

Dozens dead from Maui wildfires: What we know about the victims

Medical mystery: When a cough is not just a cough

leisure time

explore

focus

hotspot